Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Generally Safe News

Generally Safe News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Generally Safe. Real-time updates on events, politics, business and more.

Takeda Intends to Rapidly Initiate the First Global Phase 3 Trials of TAK861 an Oral Orexin Agonist in Narcolepsy Type 1 in First Half of Fiscal Year 2024

February 9, 2024
Takeda TSE4502NYSETAK today announced positive topline results from a randomized doubleblind placebocontrolled multiple dose Phase 2b trial evaluating TAK861 an oral orexin receptor 2 OX2R agonist in patients with narcolepsy type 1.
United States Yuko Yoneyama Takeda Pharmaceutical Company Limited Exchange Commission Upcoming Scientific Congress Key Secondary Endpoints Were Met
Source: businesswireindia.com

Takeda Intends to Rapidly Initiate the First Global Phase 3 Trials of TAK-861, an Oral Orexin Agonis

February 9, 2024
− Primary and Key Secondary Endpoints Were Met in Narcolepsy Type 1 Phase 2b Trial− TAK-861 Was Found to be Generally Safe and Well-Tolerated− Results Will be Presented at an Upcoming Scientific CongressOSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced positive topline resu...
United States Yuko Yoneyama Upcoming Scientific Congress Takeda Pharmaceutical Company Limited Exchange Commission Key Secondary Endpoints Were Met
Source: pharmiweb.com

Arbutus Biopharma : Preliminary Data Shows that Arbutus' Capsid Inhibitor, AB-836 is Generally Safe and Well-Tolerated and Provides Robust Antiviral Activity - Form 8-K

December 1, 2021
Preliminary Data Shows that Arbutus Capsid Inhibitor, AB-836 is Generally Safe and Well-Tolerated and Provides Robust Antiviral Activity WARMINSTER, Pa., Dec. 01, 2021 --... | December 1, 2021
United States Gaston Picchio Lisam Caperelli Williamh Collier Arbutus Biopharma Corporation Nasdaq World Health Organization
Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science